REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 39 filers reported holding REPARE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $35,994,922 | +13.5% | 3,016,674 | +0.6% | 14.27% | +48.2% |
Q2 2023 | $31,726,606 | +7.5% | 2,998,734 | +0.0% | 9.63% | +22.9% |
Q1 2023 | $29,499,719 | -28.4% | 2,997,939 | +7.1% | 7.83% | -28.6% |
Q4 2022 | $41,189,854 | +10.6% | 2,800,126 | -8.8% | 10.97% | +9.6% |
Q3 2022 | $37,237,000 | +0.6% | 3,069,847 | +16.0% | 10.01% | -29.2% |
Q2 2022 | $37,028,000 | +0.7% | 2,646,781 | +2.5% | 14.14% | -9.5% |
Q1 2022 | $36,755,000 | -21.2% | 2,581,097 | +16.7% | 15.63% | +0.9% |
Q4 2021 | $46,656,000 | -20.4% | 2,212,256 | -0.9% | 15.49% | -9.4% |
Q3 2021 | $58,588,000 | -26.0% | 2,232,783 | -12.1% | 17.10% | -7.2% |
Q2 2021 | $79,186,000 | +0.8% | 2,539,644 | -0.8% | 18.42% | +17.1% |
Q1 2021 | $78,588,000 | -9.5% | 2,560,703 | +1.1% | 15.73% | -35.7% |
Q4 2020 | $86,853,000 | +11.5% | 2,532,150 | +0.1% | 24.47% | -11.7% |
Q3 2020 | $77,863,000 | +0.3% | 2,530,494 | +1.1% | 27.70% | -8.6% |
Q2 2020 | $77,656,000 | – | 2,503,408 | – | 30.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 2,532,150 | $86,853,000 | 24.47% |
MPM ASSET MANAGEMENT LLC | 3,003,772 | $103,029,000 | 14.58% |
MPM BioImpact LLC | 4,776,674 | $163,840,000 | 14.15% |
BVF INC/IL | 2,972,191 | $101,946,000 | 4.01% |
Logos Global Management LP | 676,894 | $23,217,000 | 1.99% |
Redmile Group, LLC | 2,647,696 | $90,816,000 | 1.10% |
Orbimed Advisors | 3,426,325 | $117,523,000 | 1.03% |
CLOUGH CAPITAL PARTNERS L P | 280,979 | $9,638,000 | 0.68% |
SPHERA FUNDS MANAGEMENT LTD. | 224,300 | $7,693,000 | 0.68% |
Artal Group S.A. | 570,000 | $19,551,000 | 0.42% |